Notification of Transactions of Directors & PDMRs
Updated : 16:50
11 September 2024
FDM Group (Holdings) Plc
NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARING MANAGERIAL RESPONSIBILITY OR CONNECTED PERSONS
PSP Award - 11 September 2024
On 11 September 2024 FDM Group (Holdings) plc ("FDM") granted awards over ordinary shares in the Company under the FDM 2014 Performance Share Plan (the "PSP"), as noted below.
The vesting of the awards granted to the Company's Executive Directors is subject to a performance condition based upon FDM's earnings per share assessed over a three-year performance period commencing with FDM's 2024 financial year and to all other provisions of the PSP. Details of the performance conditions will be included in FDM's 2024 Directors' Remuneration Report. Ordinarily, the awards will vest (subject to the achievement of the performance condition) following the announcement of FDM's results for its 2026 financial year.
The awards granted to the Executive Directors will not be released, so that shares can be acquired, until the end of a holding period of two years beginning on the vesting date.
As referred to in FDM's 2023 Directors' Remuneration Report, the vesting of the awards granted to the other Senior Managers referred to below and of awards granted to other group employees is subject to the satisfaction of a financial underpin and to all other provisions of the PSP.
Each award has been granted in the form of an option with an exercise price per share of £0.01.
Name | Number of shares subject to award |
Executive Directors | |
Roderick Flavell | 75,000 |
Sheila Flavell | 75,000 |
Andrew Brown | 75,000 |
Michael McLaren | 75,000 |
Other Senior Managers | |
Mark Heather | Award 1: 10,000 Award 2: 10,000 |
Jonathan Taplin | Award 1: 10,000 Award 2: 10,000 |
The notification below provides further information about these transactions.
1 | Details of the person discharging managerial responsibilities / person closely associated | ||||||||||||||||||||||||||||
(a) | Name | (i) Roderick Flavell (ii) Sheila Flavell (iii) Andrew Brown (iv) Michael McLaren (v) Mark Heather (vi) Jonathan Taplin | |||||||||||||||||||||||||||
2 | Reason for the notification | ||||||||||||||||||||||||||||
(a) | Position/Status | (i) Chief Executive Officer (ii) Chief Operating Officer (iii) Chief Commercial Officer (iv) Chief Financial Officer (v) Group Governance Director and Company Secretary (vi) Group Operations Director | |||||||||||||||||||||||||||
(b) | Initial notification / Amendment | Initial notification | |||||||||||||||||||||||||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||||||||||||||||||||||||||
(a) | Name | FDM Group (Holdings) plc | |||||||||||||||||||||||||||
(b) | LEI | 213800YR62D7GUZLMZ71 | |||||||||||||||||||||||||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||||||||||||||||||||||||||
(a) | Description of the financial instrument, type of instrument | Ordinary Shares of £0.01 | |||||||||||||||||||||||||||
Identification Code | ISIN: GB00BLWDVP51 | ||||||||||||||||||||||||||||
(b) | Nature of the transaction | Grant of awards over Ordinary Shares | |||||||||||||||||||||||||||
(c) | Price(s) and volume(s) |
| |||||||||||||||||||||||||||
(d) | Aggregated Information | ||||||||||||||||||||||||||||
- Aggregated Volume | N/A for Roderick Flavell, Sheila Flavell, Andrew Brown, and Michael McLaren (single transaction) 20,000 for Mark Heather and 20,000 Jonathan Taplin | ||||||||||||||||||||||||||||
- Price | Nil for each PDMR | ||||||||||||||||||||||||||||
(e) | Date of the Transaction | 11 September 2024 | |||||||||||||||||||||||||||
(f) | Place of the Transaction | Outside a trading venue |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.